PPCB News and Press, Propanc Biopharma Inc.

MELBOURNE, Australia, June 16, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announ...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X (SOXS) fell 24.4% to $4.97 on volume of 883,191,047 shares Aditxt Inc. (ADTX) fell 29.7% to $0.013 on volume of 595,606,788 shares Direxion Small Cap Bear 3X (TZA) fell 8.8% to $4.27 on volume of 333...

2026-06-11 12:09:00 ET For early-stage life sciences plays, deploying capital into a buyback program serves to validate management's view of a company's pipeline value. Today, an international developer focused on treating metastatic solid-tumor cancers triggered a triple-digit single-sessi...

Boca Raton, United States, June 11, 2026 (GLOBE NEWSWIRE) -- ShareStructure.io is proud to announce the launch of its free financial education and research platform focused on helping investors better understand public company capital structures, SEC filings, dilution risks, financing transac...

2026-06-11 10:11:45 ET Denver, Colorado ( www.247marketnews.com ) – Today's market action highlighted a familiar theme across the small-cap landscape: investors continue searching for transformative growth stories amid a market increasingly driven by company-specific catalyst...

A look at the top 10 most actives in the United States Aditxt Inc. (ADTX) fell 17.3% to $0.015301 on volume of 378,944,670 shares Direxion Daily Semiconductor Bear 3X (SOXS) fell 10.4% to $5.89 on volume of 164,597,491 shares Theriva Biologics, Inc. (TOVX) rose 75.7% to $0.427801 on volume ...

2026-06-11 08:56:21 ET More on Propanc Biopharma, Inc. Historical earnings data for Propanc Biopharma, Inc. Financial information for Propanc Biopharma, Inc. Read the full article on Seeking Alpha For further details see: Propanc Biopharma authorizes $5M ...

MELBOURNE, Australia, June 11, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announ...

MELBOURNE, Australia, June 02, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announ...

MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announc...